MedTrace Logo

Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Pulse Oximeter

NCT04953507 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2025-07-18

No results posted yet for this study

Summary

The aim of the study is to compare the efficacy of T2, T3 sympathetic block using thermal radiofrequency versus chemical neurolysis in postmastectomy pain syndrome using perfusion index derived from pulse oximetry.

Conditions

  • Analgesia

Interventions

PROCEDURE

Thermal Radiofrequency

Radiofrequency lesioning at level of T2 and T3 using 80°c for 120 seconds

PROCEDURE

Chemical Neurolysis

injection of 1.5 ml of the chemical neurolytic agent (phenol in saline 8%) at each level

Sponsors & Collaborators

  • National Cancer Institute, Egypt

    lead OTHER

Principal Investigators

  • Walaa Y Elsabeeny, MD · Assistant Professor of Anesthesia and Pain Management, National Cancer Institute, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-03
Primary Completion
2025-02-10
Completion
2025-02-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953507 on ClinicalTrials.gov